Search Results 2101-2110 of 16201 for Epilepsy (Partial Onset)

1. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   ... partial thromboplastin time (PTT) within normal limits (+15%). Patients on anticoagulation must have coagulation values within the therapeutic range ...

2. Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID) - Mayo Clinic

   During the early phases (phases 1 and 2), researchers assess safety, side ... duration of the trial: HD ≥2 times per week or PD ≥4 times per week ...

3. Acute Procedural Pain Treated With Remote Electrical Neuromodulation in Chronic Migraine Patients Receiving Onabotulinumtoxina - Mayo Clinic

   Participants with uncontrolled epilepsy. Change in migraine preventive medications (type or dose) in the last two months prior to recruitment and/or during ...

4. A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia (enrollment by invitation only) - Mayo Clinic

   The reliability of sexual abstinence should be evaluated in relation to the duration of the clinical trial and the preferred and usual lifestyle of the patient.

5. Evaluating VR Therapy Using Cold Pressor Test - Mayo Clinic

   dysfunctions, pregnancy, Raynaud's disease, epilepsy, severe mental disorders, chronic pain conditions, or diseases producing neuropathic pain; Participants ...

6. Children’s Center - 2023 Archives - Mayo Clinic News Network

   December 6, 2023. Consumer Health: Epilepsy in children. Laurel Kelly ... 'Dogtor' and doctor return joy to boy with severe epilepsy. Susan Barber ...

7. An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE - Mayo Clinic

   This is a multicenter, open-label trial to evaluate the safety and efficacy of inhaled treprostinil in subjects with pre-capillary pulmonary hypertension (PH) ...

8. Leukemia - Care at Mayo Clinic

   Mayo Clinic hematologists, hematopathologists, radiation oncologists and transplant specialists work together to ensure all of your individual needs are ...

9. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   Confirmed COVID-19: the Baseline visit must be at least 14 days from onset of signs/symptoms or positive SARS-CoV-2 test, symptomatic subjects must have ...

10. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic experts research and test new treatments for focal segmental glomerulosclerosis (FSGS) through the Mayo Nephrology Collaborative Group. As ...